Delivery Order SPE2DR25D1100-SPE2DR26FDA8A
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,657.85 to AmerisourceBergen Drug Corp for Eucrisa 2% Ointment (60 grams) on November 5, 2025, with completion targeted for November 6, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $8,597.41 to Amerisourcebergen Drug Corp on January 21, 2026, for the supply of Eucrisa 2% Ointment in 60-gram quantities. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 22, 2026, and represents a task order executed against a larger contract vehicle. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $2,467.27 to AmerisourceBergen Drug Corp for the supply of Eucrisa 2% Ointment (60gm) on December 2, 2025, with completion required by December 3, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contractor's corporate office location in Conshohocken, Pennsylvania also serves...
- The Defense Logistics Agency awarded a delivery order valued at $1,956.74 to AmerisourceBergen Drug Corp for Eucrisa 2% Ointment (60gm), with an ultimate completion date of November 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Eucrisa 2% Ointment in 60-gram quantities, with a ceiling value of $1,688.16. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. The delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,468.71 to AmerIsourcebergen Drug Corp for EUCRISA 2% Ointment (60 grams) on January 7, 2026, with an ultimate completion date of January 8, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerIsourcebergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,227.91 to AmerisourceBergen Drug Corp for EUCRISA 2% Ointment in 60-gram units. This firm fixed-price, non-set-aside contract was awarded on December 11, 2025, with an ultimate completion date of December 12, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $4,305.06, is for the supply of Eucrisa 2% Ointment 60 GM to DLA facilities in support of the U.S. Armed Forces and other government agencies. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA valued at up to...
- The Defense Logistics Agency awarded a $3,664.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 grams of EUCRISA 2% Ointment, with an ultimate completion date of January 7, 2026. This competitively awarded, non-set-aside contract was issued on January 6, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for...
- This contract award is for the pharmaceutical product Eucrisa 2% Ointment 60GM, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,376.53 firm fixed-price delivery order contract has an ultimate completion date of August 15, 2024. There is no set-aside designation, indicating this was an open competition. AmerisourceBergen, as the prime contractor, has an extensive Indefinite Delivery Contract (IDC) valued at $999,999,999 with...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FDA8ADelivery Order
This delivery order, valued at $1,538.37, awards AmerIsourceBergen Drug Corp the supply of Eucrisa 2% Ointment in 60-gram quantities under a Defense Logistics Agency (DLA) contract with a firm fixed price structure. The award was made on January 21, 2026, with an ultimate completion date of January 22, 2026, and carries no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, which serves as the corporate headquarters for AmerIsourceBergen Drug Corp. This delivery order represents a small-value transaction within the contractor's broader federal pharmaceutical supply portfolio. This delivery order is issued under AmerIsourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent company, Cencora, Inc. (doing business as AmerIsourceBergen), holds a more expansive IDC with the DLA valued at up to $999,999,999.00 through December 31, 2031. These comprehensive vehicles enable the contractor to supply pharmaceutical products and medical supplies to support military healthcare programs globally, serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerIsourceBergen's consistent successful competition for federal pharmaceutical contracts demonstrates its established capability as a critical vendor in the federal medical procurement supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 1/20/26 |